AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $75.7 million versus the consensus estimate of $72.7 million.

GUIDANCE:

AngioDynamics sees FY2026 EPS of ($0.23)-($0.33), versus the consensus of ($0.31). AngioDynamics sees FY2026 revenue of $308-313 million, versus the consensus of $307.5 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.